iShares Biotechnology ETF (IBB) saw an estimated $98.3 million outflow week over week, equal to a 1.3% decline in shares outstanding. The move points to modest softening in investor positioning toward biotech, though the article is purely flow-based and does not indicate any fundamental change in the sector.
iShares Biotechnology ETF (IBB) saw an estimated $98.3 million outflow week over week, equal to a 1.3% decline in shares outstanding. The move points to modest softening in investor positioning toward biotech, though the article is purely flow-based and does not indicate any fundamental change in the sector.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.12